Sodium valproate induced alopecia: A case series

Sereen Rose Thomson, Vinay Mamulpet, Shalini Adiga

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Drug induced alopecia may range from a barely detectable shedding to an irreversible baldness. Alopecia associated with valproate is a dose-dependent and reversible side effect. We hereby report, three cases of alopecia that occurred in patients who received sodium valproate for various neurological conditions. In all three cases, long term exposure of valproate therapy led to the development of alopecia which eventually resolved after dose reduction or discontinuation. The Naranjo’s causality assessment scale indicated valproate as the probable cause of the alopecia in all our patients.

Original languageEnglish
Pages (from-to)FR01-FR02
JournalJournal of Clinical and Diagnostic Research
Volume11
Issue number9
DOIs
Publication statusPublished - 01-09-2017

Fingerprint

Alopecia
Valproic Acid
Implosive Therapy
Causality
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Clinical Biochemistry

Cite this

Thomson, Sereen Rose ; Mamulpet, Vinay ; Adiga, Shalini. / Sodium valproate induced alopecia : A case series. In: Journal of Clinical and Diagnostic Research. 2017 ; Vol. 11, No. 9. pp. FR01-FR02.
@article{594ae200d2cc4c9b8e0cc52280ca6212,
title = "Sodium valproate induced alopecia: A case series",
abstract = "Drug induced alopecia may range from a barely detectable shedding to an irreversible baldness. Alopecia associated with valproate is a dose-dependent and reversible side effect. We hereby report, three cases of alopecia that occurred in patients who received sodium valproate for various neurological conditions. In all three cases, long term exposure of valproate therapy led to the development of alopecia which eventually resolved after dose reduction or discontinuation. The Naranjo’s causality assessment scale indicated valproate as the probable cause of the alopecia in all our patients.",
author = "Thomson, {Sereen Rose} and Vinay Mamulpet and Shalini Adiga",
year = "2017",
month = "9",
day = "1",
doi = "10.7860/JCDR/2017/28564.10658",
language = "English",
volume = "11",
pages = "FR01--FR02",
journal = "Journal of Clinical and Diagnostic Research",
issn = "2249-782X",
publisher = "Journal of Clinical and Diagnostic Research",
number = "9",

}

Sodium valproate induced alopecia : A case series. / Thomson, Sereen Rose; Mamulpet, Vinay; Adiga, Shalini.

In: Journal of Clinical and Diagnostic Research, Vol. 11, No. 9, 01.09.2017, p. FR01-FR02.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Sodium valproate induced alopecia

T2 - A case series

AU - Thomson, Sereen Rose

AU - Mamulpet, Vinay

AU - Adiga, Shalini

PY - 2017/9/1

Y1 - 2017/9/1

N2 - Drug induced alopecia may range from a barely detectable shedding to an irreversible baldness. Alopecia associated with valproate is a dose-dependent and reversible side effect. We hereby report, three cases of alopecia that occurred in patients who received sodium valproate for various neurological conditions. In all three cases, long term exposure of valproate therapy led to the development of alopecia which eventually resolved after dose reduction or discontinuation. The Naranjo’s causality assessment scale indicated valproate as the probable cause of the alopecia in all our patients.

AB - Drug induced alopecia may range from a barely detectable shedding to an irreversible baldness. Alopecia associated with valproate is a dose-dependent and reversible side effect. We hereby report, three cases of alopecia that occurred in patients who received sodium valproate for various neurological conditions. In all three cases, long term exposure of valproate therapy led to the development of alopecia which eventually resolved after dose reduction or discontinuation. The Naranjo’s causality assessment scale indicated valproate as the probable cause of the alopecia in all our patients.

UR - http://www.scopus.com/inward/record.url?scp=85030625552&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030625552&partnerID=8YFLogxK

U2 - 10.7860/JCDR/2017/28564.10658

DO - 10.7860/JCDR/2017/28564.10658

M3 - Article

AN - SCOPUS:85030625552

VL - 11

SP - FR01-FR02

JO - Journal of Clinical and Diagnostic Research

JF - Journal of Clinical and Diagnostic Research

SN - 2249-782X

IS - 9

ER -